Parkinson Disease vs Dementia with Lewy Bodies
Parkinson Disease and Dementia with Lewy Bodies are easy to mix up on the boards. Here's a side-by-side comparison — presentation, workup, imaging, and first-line treatment — drawn from our full outlines.
Parkinson Disease vs Dementia with Lewy Bodies at a glance
- Parkinson Disease: Progressive neurodegenerative movement disorder from nigrostriatal dopamine loss.
- Dementia with Lewy Bodies: Neurodegenerative dementia with fluctuating cognition, recurrent visual hallucinations, parkinsonism, and REM sleep behavior disorder.
Keep comparing — start your free trial
You've used your 2 free previews. Create your free account to see the full Parkinson Disease vs Dementia with Lewy Bodies comparison — plus all 514 diagnosis outlines, 6,400+ board-style questions, and an AI tutor. Your 7-day free trial includes everything, no credit card required.
Side-by-side comparison
| Feature | Parkinson Disease | Dementia with Lewy Bodies |
|---|---|---|
| At a glance | Progressive neurodegenerative movement disorder from nigrostriatal dopamine loss. | Neurodegenerative dementia with fluctuating cognition, recurrent visual hallucinations, parkinsonism, and REM sleep behavior disorder. |
| Classic presentation | Asymmetric rest tremor + bradykinesia + cogwheel rigidity with excellent response to levodopa is highly suggestive.; Motor: rest tremor (typically asymmetric, 4-6 Hz 'pill-rolling'), bradykinesia (slowness initiating and executing movement), rigidity (cogwheel or lead-pipe), postural instability (later); Gait: shuffling, short steps,… | Elderly patient with fluctuating cognition + well-formed visual hallucinations + parkinsonism + history of acting out dreams.; Cognitive fluctuations: pronounced day-to-day or hour-to-hour variation in attention, alertness, and coherence; Recurrent visual hallucinations — typically well-formed people or animals, often non-threatening;… |
| Workup / key labs | MDS clinical diagnostic criteria: bradykinesia plus rest tremor and/or rigidity; supported by clear levodopa response, levodopa-induced dyskinesia, rest tremor, olfactory loss; red flags suggesting atypical parkinsonism must be absent.; Largely a clinical diagnosis; labs to exclude mimics: TSH, CBC, BMP, B12; Consider ceruloplasmin in… | McKeith 2017 criteria: dementia + core features (fluctuating cognition, visual hallucinations, RBD, parkinsonism). Probable DLB = ≥2 core features OR 1 core + ≥1 indicative biomarker (DaTscan, MIBG, polysomnography-confirmed RBD).; TSH, B12, syphilis, HIV (reversible cognitive impairment screen); Comprehensive metabolic panel;… |
| Imaging | MRI brain — usually normal in PD; helps exclude vascular disease, NPH, atypical parkinsonism; DaTscan (123I-ioflupane SPECT) — shows reduced striatal dopamine transporter binding; differentiates PD/atypical parkinsonism from essential tremor or drug-induced parkinsonism, but does NOT distinguish PD from MSA/PSP/CBD; Levodopa challenge —… | MRI brain — relative sparing of medial temporal lobes (vs prominent hippocampal atrophy in AD); DaTscan SPECT — reduced striatal dopamine transporter uptake (indicative biomarker); FDG-PET — occipital hypometabolism with cingulate island sign; MIBG cardiac scintigraphy — reduced uptake reflecting cardiac sympathetic denervation |
| First-line treatment | Levodopa/carbidopa — most effective symptomatic therapy; carbidopa inhibits peripheral DOPA decarboxylase to reduce nausea and increase central availability; start low (25/100 TID) and titrate; Dopamine agonist — pramipexole, ropinirole, rotigotine (transdermal); often preferred initial therapy in younger patients to delay… | Cholinesterase inhibitors — rivastigmine (oral or transdermal), donepezil, galantamine — among the most responsive dementias to these agents; reduce hallucinations and improve cognition; Memantine — adjunct in moderate-severe disease; Carbidopa-levodopa for parkinsonism — start low, titrate slowly; full PD doses risk worsening… |
Drill Parkinson Disease vs Dementia with Lewy Bodies questions on FirstPassPA
Turn this comparison into retention. 6,400+ board-style questions with an AI tutor that explains every answer — free to start, no card required.
Start studying free → Try today's free questionEducational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.